Prevalence of, and risk factors for Kaposi's sarcoma-associated herpesvirus infection among blood donors in Brazil: A multi-center serosurvey

Journal of Medical Virology

Volumn 80, Issue 7, 2008, Pages 1202-1210

  Nascimento, Maria Claudia ^a,b   De Souza, Vanda Akico ^b   Sumita, Laura Masami ^b   Freire, Wilton ^b   Weiss, Helen A ^a   Sabino, Ester C ^c   Franceschi, Silvia ^d   Pannuti, Claudio Sergio ^b   Mayaud, Philippe ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Blood donors; Epidemiology; Human herpes virus 8 (HHV 8); Kaposi's sarcoma associated herpes virus (KSHV); Seroprevalence

Indexed keywords

LATENCY ASSOCIATED NUCLEAR ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; BRAZIL; CONFIDENCE INTERVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH SURVEY; HUMAN; HUMAN HERPESVIRUS 8; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; RISK FACTOR; SEROPREVALENCE; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; VIRUS DETECTION; VIRUS INFECTION; VIRUS TRANSMISSION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 8;

EID: 43949096188     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21188     Document Type: Article

References (34)

1. Baillargeon J, Deng JH, Hettler E, Harrison C, Grady JJ, Korte LG, Alexander J, Montalvo E, Jenson HB, Gao SJ. 2001. Seroprevalence of Kaposi's sarcoma‐associated herpesvirus infection among blood donors from Texas. Ann Epidemiol 11: 512–518.
2. Beral V, Peterman TA, Berkelman RL, Jaffe HW. 1990. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection? Lancet 335: 123–128.
3. Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F. 2000. Human herpesvirus 8 in Brazilian Amerindians: A hyperendemic population with a new subtype. J Infect Dis 181: 1562–1568.
4. Boshoff C, Weiss RA. 2001. Epidemiology and pathogenesis of Kaposi's sarcoma‐associated herpesvirus. Philos Trans Roy Soc Lond B: Biol Sci 356: 517–534.
5. Caterino‐de‐Araujo A, Calabro ML, de los Santos‐Fortuna E, Suleiman J, Chieco‐Bianchi L. 1999. Searching for human herpesvirus 8 antibodies in serum samples from patients infected with human immunodeficiency virus type 1 and blood donors from Sao Paulo, Brazil. J Infect Dis 179: 1591–1592.
6. Cattani P, Cerimele F, Porta D, Graffeo R, Ranno S, Marchetti S, Ricci R, Capodicasa N, Fuga L, Amico R, Cherchi G, Gazzilli M, Zanetti S, Fadda G. 2003. Age‐specific seroprevalence of human herpesvirus 8 in Mediterranean regions. Clin Microbiol Infect 9: 274–279.
7. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus‐like DNA sequences in AIDS‐associated Kaposi's sarcoma. Science 266: 1865–1869.
8. Cunha AM, Caterino‐de‐Araujo A, Costa SC, Santos‐Fortuna E, Boa‐Sorte NC, Goncalves MS, Costa FF, Galvao‐Castro B. 2005. Increasing seroprevalence of human herpesvirus 8 (HHV‐8) with age confirms HHV‐8 endemicity in Amazon Amerindians from Brazil. J Gen Virol 86: 2433–2437.
9. Dedicoat M, Newton R. 2003. Review of the distribution of Kaposi's sarcoma‐associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Brit J Cancer 88: 1–3.
10. Dukers NHTM, Rezza G. 2003. Human herpesvirus 8 epidemiology: What we do and do not know. AIDS 17: 1717–1730.
11. Enbom M, Urassa W, Massambu C, Thorstensson R, Mhalu F, Linde A. 2002. Detection of human herpesvirus 8 DNA in serum from blood donors with HHV‐8 antibodies indicates possible bloodborne virus transmission. J Med Virol 68: 264–267.
12. Engels EA, Whitby D, Goebel PB, Stossel A, Waters D, Pintus A, Contu L, Biggar RJ, Goedert JJ. 2000. Identifying human herpesvirus 8 infection: Performance characteristics of serologic assays. J Acquir Immune Defic Syndr 23: 346–354.
13. Engels EA, Atkinson JO, Graubard BI, McQuillan GM, Gamache C, Mbisa G, Cohn S, Whitby D, Goedert JJ. 2007. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 196: 199–207.
14. Ferreira S, Sanabani S, Reis AD, Chamone DF, Sabino EC. 2003. Human herpesvirus type 8 among Brazilian blood donors. Transfusion 43: 1764–1765.
15. Freitas RB, Freitas MR, Linhares AC. 2002. Prevalence of human herpesvirus 8 antibodies in the population of Belem, Para, Brazil. Rev Inst Med Trop Sao Paulo 44: 309–313.
16. Hladik W, Dollard SC, Downing RG, Kataaha P, Pellett PE, Karon JM, Mermin J, Lackritz EM. 2003. Kaposi's sarcoma in Uganda: Risk factors for human herpesvirus 8 infection among blood donors. J Acquir Immune Defic Syndr 33: 206–210.
17. Hudnall SD, Chen T, Rady P, Tyring S, Allison P. 2003. Human herpesvirus 8 seroprevalence and viral load in healthy adult blood donors. Transfusion 43: 85–90.
18. IARC. 1997. Monographs on the evaluation of carcinogenic risks to humans. Volume 70: Epstein‐Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon: International Agency for Research on Cancer. pp 375–492.
19. Lennette ET, Blackbourn DJ, Levy JA. 1996. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 348: 858–861.
20. Mohanna S, Portillo JA, Carriquiry G, Vidal J, Ferrufino JC, Sanchez J, Bravo F, Gotuzzo E. 2007. Human herpesvirus‐8 in Peruvian blood donors: A population with hyperendemic disease? Clin Infect Dis 44: 558–561.
21. Nascimento MC, de Souza VA, Sumita LM, Freire W, Munoz F, Kim J, Pannuti CS, Mayaud P. 2007a. Comparative study of Kaposi's sarcoma‐associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis. J Clin Microbiol 45: 715–720.
22. Nascimento MC, Ferreira S, Sabino E, Hamilton I, Parry J, Pannuti CS, Mayaud P. 2007b. Performance of the HerpeSelect (Focus) and Kalon enzyme‐linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody‐blocking enzyme immunoassay and clinicovirological reference standards in Brazil. J Clin Microbiol 45: 2309–2311.
23. Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C. 2003. The sero‐epidemiology of Kaposi's sarcoma‐associated herpesvirus (KSHV/HHV‐8) in adults with cancer in Uganda. Int J Cancer 103: 226–232.
24. Obasi A, Mosha F, Quigley M, Sekirassa Z, Gibbs T, Munguti K, Todd J, Grosskurth H, Mayaud P, Changalucha J, Brown D, Mabey D, Hayes R. 1999. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis 179: 16–24.
25. Parkin DM, Whelan SL, Ferlay J, Thomas DB, Teppo L, editors. 2002. Cancer incidence in five continents, Vol. VIII. IARC Scientific Publications No. 155 Lyon: International Agency for Research on Cancer.
26. Plancoulaine S, Abel L, van Beveren M, Tregouet DA, Joubert M, Tortevoye P, de The G, Gessain A. 2000. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356: 1062–1065.
27. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. 1996. Nucleotide sequence of the Kaposi sarcoma‐associated herpesvirus (HHV8). Proc Natl Acad Sci USA 93: 14862–14867.
28. Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Jentsch U, Pacella‐Norman R, Bourboulia D, Whitby D, Boshoff C, Weiss R. 1999. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 340: 1863–1871.
29. Smith NA, Sabin CA, Gopal R, Bourboulia D, Labbet W, Boshoff C, Barlow D, Band B, Peters BS, De Ruiter A, Brown DW, Weiss RA, Best JM, Whitby D. 1999. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis 180: 600–606.
30. Tedeschi R, Bidoli E, Agren A, Hallmans G, Wadell G, De Paoli P, Dillner J. 2006. Epidemiology of Kaposi's sarcoma herpesvirus (HHV8) in Vasterbotten County, Sweden. J Med Virol 78: 372–378.
31. Volpi A, Sarmati L, Suligoi B, Montano M, Rezza G, Andreoni M. 2004. Correlates of human herpes virus‐8 and herpes simplex virus type 2 infections in Northern Cameroon. J Med Virol 74: 467–472.
32. Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Makinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C. 2004. Kaposi sarcoma herpesvirus‐induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36: 687–693.
33. Wojcicki JM, Newton R, Urban MI, Stein L, Hale M, Patel M, Ruff P, Sur R, Bourboulia D, Sitas F. 2003. Risk factors for high anti‐HHV‐8 antibody titers (> or = 1:51,200) in black, HIV‐1 negative South African cancer patients: A case control study. BMC Infect Dis 3: 21.
34. Zago A, Bourboulia D, Viana MC, Collandre H, Dietze R, Boshoff C, Keller R. 2000. Seroprevalence of human herpesvirus 8 and its association with Kaposi sarcoma in Brazil. Sex Transm Dis 27: 468–472.